Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.

Zobrazit další vydání (1)

OBJECTIVES: Observational and genetic studies have shown that lipoprotein(a) [Lp(a)] levels and apolipoprotein(a) [apo(a)] isoform size are both associated with coronary heart disease (CHD) risk, but the relative independence of these risk factors remains unclear. Clarification of this uncertainty i...

Podrobná bibliografie
Hlavní autoři:	Hopewell, J, Seedorf, U, Farrall, M, Parish, S, Kyriakou, T, Goel, A, Hamsten, A, Collins, R, Watkins, H, Clarke, R
Médium:	Journal article
Jazyk:	English
Vydáno:	2014

Podobné jednotky

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
Autor: Hopewell, J, a další
Vydáno: (2014)

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
Autor: Hopewell, J, a další
Vydáno: (2010)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
Autor: Kyriakou, T, a další
Vydáno: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
Autor: Kyriakou, T, a další
Vydáno: (2014)

LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
Autor: Kyriakou, T, a další
Vydáno: (2014)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
Autor: Parish, S, a další
Vydáno: (2018)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Autor: Clarke, R, a další
Vydáno: (2009)

Independent relevance of renal function for coronary artery disease
Autor: Hopewell, J, a další
Vydáno: (2010)

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
Autor: Farrer, M, a další
Vydáno: (1994)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
Autor: Hopewell, J, a další
Vydáno: (2011)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
Autor: Clarke, R, a další
Vydáno: (2018)

Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
Autor: Clarke, R, a další
Vydáno: (2009)

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP
Autor: Goel, A, a další
Vydáno: (2009)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
Autor: Farrall, M, a další
Vydáno: (2010)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Autor: Ruotolo, G, a další
Vydáno: (1998)

COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE
Autor: Seedorf, U, a další
Vydáno: (2010)

Independent Relevance of Cytokines for Risk of Coronary Heart Disease
Autor: Clarke, R, a další
Vydáno: (2012)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
Autor: Anastasiya Matveyenko, a další
Vydáno: (2023-03-01)

Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease
Autor: Clarke, R, a další
Vydáno: (2023)

Oxidized phospholipids, Lp(a) and coronary heart disease risk
Autor: Clarke, R, a další
Vydáno: (2012)

Lipoprotein(a) Genetic Variants Associated With Risk of Atherothrombotic Disease in 14,465 Participants From the Heart Protection Study
Autor: Hopewell, J, a další
Vydáno: (2010)

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
Autor: Parish, S, a další
Vydáno: (2012)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
Autor: K. I. Tebloev, a další
Vydáno: (2005-10-01)

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
Autor: Stefania Lamon-Fava, a další
Vydáno: (2011-06-01)

Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer’s disease
Autor: Grace, PC, a další
Vydáno: (2018)

Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
Autor: R W Mahley, a další
Vydáno: (1995-04-01)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
Autor: Hopewell, J, a další
Vydáno: (2012)

USE OF ENCODE DATA TO IDENTIFY PUTATIVE FUNCTIONAL VARIANTS IN CORONARY ARTERY DISEASE GWAS
Autor: Goel, A, a další
Vydáno: (2014)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
Autor: Dick C. Chan, a další
Vydáno: (2019-04-01)

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.
Autor: Broadbent, H, a další
Vydáno: (2008)

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p
Autor: Broadbent, H, a další
Vydáno: (2008)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
Autor: Yahui Lin, a další
Vydáno: (2022-02-01)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
Autor: Karpe, F, a další
Vydáno: (1994)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
Autor: F Karpe, a další
Vydáno: (1994-07-01)

Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease.
Autor: Hamsten, A, a další
Vydáno: (1994)

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
Autor: Junfeng Zhang, a další
Vydáno: (2023-11-01)

Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
Autor: Waldomiro Carlos Manfroi, a další
Vydáno: (1999-06-01)

Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study.
Autor: Peacock, R, a další
Vydáno: (1995)

Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
Autor: Clarke, R, a další
Vydáno: (2007)

The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
Autor: A. M. Kaneva, a další
Vydáno: (2018-06-01)